Validea Detailed Fundamental Analysis

Validea's guru fundamental report indicates Tesla (TSLA) received a 66% rating from its P/B Growth Investor model, based on Partha Mohanram's academically-derived strategy for identifying sustainable growth in low book-to-market stocks. While TSLA passed key fundamental tests including book/market ratio and return on assets, it failed criteria such as sales variance and R&D to assets. This 66% score, falling below the 80% threshold for 'some interest,' suggests TSLA does not currently align strongly with the characteristics identified by this historically outperforming growth model.

Analysis

According to a Validea fundamental report, Tesla Inc. (TSLA) scores 66% on the P/B Growth Investor model, which is based on the academic strategy of Partha Mohanram. This model is designed to identify low book-to-market stocks with characteristics pointing to sustained future growth. A 66% rating is notably below the 80% threshold that typically indicates model interest, suggesting TSLA does not currently meet the key criteria for a high-conviction growth investment under this specific framework. While the company passes on several fundamental metrics including its book-to-market ratio, return on assets (ROA), and cash flow from operations, it fails on criteria for sales variance, advertising to assets, and research and development to assets. The failure on sales variance may signal inconsistency in its growth trajectory, a significant concern for a growth-oriented stock, while the R&D metric failure could challenge perceptions of its innovation pipeline relative to its asset scale.

Key Decisions for Investors

• Investors employing quantitative growth strategies should note that TSLA's 66% score on the Mohanram model falls below the 80% threshold for 'some interest', indicating a lack of alignment with this academically-backed screen for sustainable growth.
• The model's specific failure points, particularly on 'Sales Variance' and 'Research and Development to Assets', warrant closer scrutiny as they may signal potential volatility in revenue growth and questions about the efficiency of R&D spending relative to the company's size.
• Given the mixed results, where TSLA passes on profitability and cash flow metrics but fails on growth consistency, a neutral stance may be prudent for investors who weigh these specific quantitative factors heavily.